跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
FOLOTYN pralatrexate 40 mg in 2 mL injection, intravenous infusion vial - TGA Drug Approval Details
Approvals
/
TGA
/
FOLOTYN pralatrexate 40 mg in 2 mL injection, intravenous infusion vial
Approved
STANDARD
FOLOTYN pralatrexate 40 mg in 2 mL injection, intravenous infusion vial
Mundipharma Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
0302eb2e3567eea4
Company
Mundipharma Pty Ltd
Type
Standard
Approval Details
Approval Id
0302eb2e3567eea4
Product Name
FOLOTYN pralatrexate 40 mg in 2 mL injection, intravenous infusion vial
Artg Id
192492
Artg Name
FOLOTYN pralatrexate 40 mg/2 mL injection, intravenous infusion vial
Sponsor
Mundipharma Pty Ltd
Company Detail Path
/organization/mundipharma-pty-ltd
Artg Date
2015-02-26
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/d5ee3484f33cc633d71e8f62c132f042.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/dbe760f17510e5bced8b9829bfb1ef63.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
0302eb2e3567eea4
Type
Standard
Back to TGA Approvals